| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |